EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers

Ole Haubjerg Nielsen iD, Ulrik Kristoffer Stoltze iD, Pernille Axél Gregersen iD, Marianne Hoffmann, Morten Lyng Høgild, Mette Klarskov Andersen, Lise Barlebo Ahlborn iD, Lisa Lyngsie Hjalgrim, Karin A W Wadt

American Journal of Medical Genetics Part A · 08.08.2026

DOI: 10.1002/ajmg.a.70256 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 08.08.2026. Verfasst von Ole Haubjerg Nielsen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report a patient with a pathogenic germline variant (PGV) in RB1 and somatic mosaicism for a pathogenic TP53 variant who developed three distinct types of childhood cancer: retinoblastoma, osteosarcoma, and myelodysplastic syndrome (MDS) before the age of 6 years. The patient presented with bilateral retinoblastoma at age 4 weeks and a PGV in RB1 was found. At the very young age of 3 years, she developed an osteosarcoma. A pathogenic variant in TP53 was initially found in bone marrow as part of the diagnostic workup for the patient's third cancer, MDS rapidly progressing to acute myeloid leukemia (AML). Due to the unusual clinical phenotype, cultured fibroblasts from a skin biopsy were examined and identified somatic TP53 mosaicism, with a VAF of 7%. The early debut of osteosarcoma at age 3 years indicates a stronger predisposition than only heritable retinoblastoma would explain, but the development of subsequent MDS could implicate a vulnerability to chemotherapy due to digenic cancer predisposition. This unusual clinical course underlines the need for a better understanding of genetic predisposition to cancer and the interplay between genetic predisposition and treatment effects in optimizing therapeutic strategies and improving long‐term outcomes for these patients.

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
  • Centre for Rare Diseases, Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
  • Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Ole Haubjerg Nielsen, Ulrik Kristoffer Stoltze, Pernille Axél Gregersen, Lise Barlebo Ahlborn

Zitieren

APA

Nielsen, O. H., Stoltze, U. K., Gregersen, P. A., Hoffmann, M., Høgild, M. L., Andersen, M. K., Ahlborn, L. B., Hjalgrim, L. L., & Wadt, K. A. W. (2026). Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.70256

Vancouver

Nielsen OH, Stoltze UK, Gregersen PA, Hoffmann M, Høgild ML, Andersen MK, et al. Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers. American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmg.a.70256

BibTeX
@article{Nielsen2026,
  author = {Nielsen, Ole Haubjerg and Stoltze, Ulrik Kristoffer and Gregersen, Pernille Axél and Hoffmann, Marianne and Høgild, Morten Lyng and Andersen, Mette Klarskov and Ahlborn, Lise Barlebo and Hjalgrim, Lisa Lyngsie and Wadt, Karin A W},
  title = {Concurrent Germline RB1 & Mosaic TP53 in a Child With Multiple Childhood Cancers},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmg.a.70256}
}
Kostenlos starten →